FDA Inspection 1023652 — Patheon Softgels Inc
The FDA completed an inspection of Patheon Softgels Inc on Aug 11, 2017 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 11, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- High Point, NC (United States)